Smoking and progression of diabetic nephropathy in patients with type 1 diabetes

Acta Diabetologica

Volumn 53, Issue 4, 2016, Pages 525-533

  Feodoroff, Maija ^a,b   Harjutsalo, Valma ^a,b,c   Forsblom, Carol ^a,b   Thorn, Lena ^a,b   Wadén, Johan ^a,b   Tolonen, Nina ^a,b   Lithovius, Raija ^a,b   Groop, Per Henrik ^a,b,d  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Diabetic nephropathy; End stage renal disease; Macroalbuminuria; Microalbuminuria; Smoking; Smoking cessation; Type 1 diabetes

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; END STAGE RENAL DISEASE; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MACROALBUMINURIA; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SMOKING HABIT; ADVERSE EFFECTS; ALBUMINURIA; COMPLICATION; DIABETIC NEPHROPATHIES; FINLAND; KIDNEY FAILURE, CHRONIC; REGRESSION ANALYSIS; URINE;

ADULT; ALBUMINURIA; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FINLAND; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 84949788346     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-015-0822-0     Document Type: Article

References (32)

1. Jha P, Ramasundarahettige C, Landsman V et al (2013) 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med 368:341–350
2. Pirie K, Peto R, Reeves GK, Green J, Beral V, Million Women Study C (2013) The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet 381:133–141
3. Haroun MK, Jaar BG, Hoffman SC, Comstock GW, Klag MJ, Coresh J (2003) Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. J Am Soc Nephrol 14:2934–2941
4. Hallan SI, Orth SR (2011) Smoking is a risk factor in the progression to kidney failure. Kidney Int 80:516–523
5. U.S. Renal Data System (2013) USRDS 2013 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda
6. Jacobsen P, Rossing K, Tarnow L et al (1999) Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int Suppl 71:S101–S105
7. Jenkins AJ, Lyons TJ, Zheng D et al (2003) Lipoproteins in the DCCT/EDIC cohort: associations with diabetic nephropathy. Kidney Int 64:817–828
8. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2003) Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 290:2159–2167
9. Chase HP, Garg SK, Marshall G et al (1991) Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 265:614–617
10. Muhlhauser I, Sawicki P, Berger M (1986) Cigarette-smoking as a risk factor for macroproteinuria and proliferative retinopathy in type 1 (insulin-dependent) diabetes. Diabetologia 29:500–502
11. Sawicki PT, Didjurgeit U, Muhlhauser I, Bender R, Heinemann L, Berger M (1994) Smoking is associated with progression of diabetic nephropathy. Diabetes Care 17:126–131
12. Couper JJ, Staples AJ, Cocciolone R, Nairn J, Badcock N, Henning P (1994) Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabetes Med 11:666–669
13. Scott LJ, Warram JH, Hanna LS, Laffel LM, Ryan L, Krolewski AS (2001) A nonlinear effect of hyperglycemia and current cigarette smoking are major determinants of the onset of microalbuminuria in type 1 diabetes. Diabetes 50:2842–2849
14. Rossing P, Hougaard P, Parving HH (2002) Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study. Diabetes Care 25:859–864
15. Hovind P, Rossing P, Tarnow L, Parving HH (2003) Smoking and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 26:911–916
16. Hovind P, Tarnow L, Rossing P et al (2004) Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ 328:1105
17. Chaturvedi N, Stephenson JM, Fuller JH (1995) The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study. Diabetes Care 18:785–792
18. Giorgino F, Laviola L, Cavallo Perin P, Solnica B, Fuller J, Chaturvedi N (2004) Factors associated with progression to macroalbuminuria in microalbuminuric type 1 diabetic patients: the EURODIAB Prospective Complications Study. Diabetologia 47:1020–1028
19. Gerber PA, Locher R, Schmid B, Spinas GA, Lehmann R (2013) Smoking is associated with impaired long-term glucose metabolism in patients with type 1 diabetes mellitus. Nutr Metab Cardiovasc Dis 23:102–108
20. Orth SR, Schroeder T, Ritz E, Ferrari P (2005) Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. Nephrol Dial Transplant 20:2414–2419
21. Thorn LM, Forsblom C, Fagerudd J et al (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019–2024
22. Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604–612
23. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ (2000) Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49:626–632
24. Barua RS, Ambrose JA (2013) Mechanisms of coronary thrombosis in cigarette smoke exposure. Arterioscler Thromb Vasc Biol 33:1460–1467
25. Nilsson PM, Gudbjornsdottir S, Eliasson B, Cederholm J, Steering Committee of the Swedish National Diabetes Register (2004) Smoking is associated with increased HbA1c values and microalbuminuria in patients with diabetes–data from the National Diabetes Register in Sweden. Diabetes Metab 30:261–268
26. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM (1992) Insulin resistance and cigarette smoking. Lancet 339:1128–1130
27. Axelsson T, Jansson PA, Smith U, Eliasson B (2001) Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects. J Intern Med 249:539–544
28. Bergman BC, Perreault L, Hunerdosse DM, Koehler MC, Samek AM, Eckel RH (2009) Intramuscular lipid metabolism in the insulin resistance of smoking. Diabetes 58:2220–2227
29. Bergman BC, Perreault L, Hunerdosse D et al (2012) Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes 61:3156–3166
30. Seet RC, Loke WM, Khoo CM et al (2012) Acute effects of cigarette smoking on insulin resistance and arterial stiffness in young adults. Atherosclerosis 224:195–200
31. Tolonen N, Forsblom C, Thorn L et al (2009) Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes. Diabetologia 52:2522–2530
32. Helakorpi S, Holstila A, Virtanen S, Uutela A (2011) Health Behaviour and Health among the Finnish Adult Population, Spring 2011. National Institute for Health and Welfare (THL). http://urn.fi/URN:ISBN:978-952-245-566-6. Accessed November 2012